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Introduction
 Public health authorities throughout the world are 
progressively introducing faecal occult blood test (FOBT)-
based population screening programs for early detection 
of colorectal cancer (CRC) that, in line with the evidence 
base, offer multiple rounds of screening. While there 
has been a substantial amount reported in the literature 
on behavioural outcomes following an initial round of 
screening offers, there is much less information available 
on patterns of participation in FOBT-based CRC screening 
over multiple rounds or on demographic or behavioural 
factors associated with participatory behaviour over more 
than one round. The lack of an agreed and useful system 
for describing participatory behaviour over multiple 
rounds also hampers our ability to report, understand 
and make use of observed associations with particular 
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Abstract
 Background: There is little information on longitudinal patterns of participation in faecal occult blood test 
(FOBT) based colorectal cancer (CRC) screening or on demographic or behavioural factors associated with 
participation in re-screening. The lack of an agreed system for describing participatory behaviour over multiple 
rounds also hampers our ability to report, understand and make use of observed associations. Our aims were to 
develop a system for describing patterns of participatory behaviour in FOBT-based CRC screening programs 
and to identify factors associated with particular behavioural patterns. Methods: A descriptive framework was 
developed and applied to a data extract of screening invitation outcomes over two rounds of the NBCSP. The 
proportion of invitees in each behaviour category was determined and associations between behaviour patterns 
and demographic and program factors were identified using multivariate analyses. Results: We considered Re-
Participants, Dropouts, Late Entrants and Never Participants to be the most appropriate labels for the four 
possible observed participatory categories after two invitation rounds. The screening participation rate of the 
South Australian cohort of the NBCSP remained stable over two rounds at 51%, with second round Dropouts 
(10.3%) being balanced by Late Entrants (10.5%). Non-Participants comprised 38.7% of invitees. Relative 
to Re-Participants, Dropouts were older, more likely to be female, of lower SES, had changed their place of 
residence between offers had a positive test result in the first round. Late Entrants tended to be in the youngest 
age band. Conclusions: Specific demographic characteristics are associated with behavioural sub-groups defined 
by responses to 2 offers of CRC screening. Targeted group-specific strategies could reduce dropout behaviour 
or encourage those who declined the first invitation to participate in the second round. It will be important to 
keep first round participants engaged in order to maximise the benefit of a CRC screening program. 
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behavioural patterns. 
	 Repeated	participation	is	crucial	to	efficacy	of	FOBT-
based	screening.	The	evidence	for	the	benefit	of	FOBT-
based screening comes from clinical trials of screening 
that involved multiple rounds of offers over a period of at 
least ten years (Mandel et al., 1993; Hardcastle et al., 1996; 
Kronborg et al., 1996; Hewitson et al., 2007; Lindholm 
et al., 2008). Results from the longest trial showed that 
mortality in those offered annual or biennial FOBT-based 
screening was reduced by 33% and 21% respectively, 
compared to a population not offered screening (Mandel 
et al., 1993). While the difference in mortality reduction 
between annual and biennial screening was not statistically 
significant,	the	trend	toward	greater	mortality	reduction	
with more testing points highlights the importance of re-
participation. 
 Invitees to Australia’s National Bowel Cancer 
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Screening Pilot Program (NBCSPP) received a second 
invitation to screen in Phase 1 of the National Bowel 
Cancer Screening Program (NBCSP). We reasoned 
that this population could, within the Australian setting, 
provide valuable information on likely population 
screening re-participation rates and might also provide 
information on demographic or program factors that 
predict an invitee’s behavioural response to a second 
screening offer. 
	 Our	specific	aims	were:	(1)	To	develop	a	simple	system	
for describing patterns of participatory behaviour; (2) 
To apply this terminology to the 2 rounds of screening 
through the NBCSP and to determine the proportion of 
people falling into each participatory category and (3) To 
determine demographic and program factors associated 
with re-screening behaviour. Our ultimate goal was to 
develop recommendations for strategies to maximise re-
participation in FOBT-screening.
 
Materials and Methods
Defining patterns of participatory behaviour
 We developed a simple and practical nomenclature 
using descriptors that covered all possible behavioural 
patterns after two rounds of offers. We categorised invitees 
into Re-Participants and Never Participants (no change 
in participatory behaviour in the second round from the 
first),	Dropouts	(participated	in	the	first	round	but	declined	
the	second)	and	Late	Entrants	(declined	the	first	offer	but	
participated in the second). We applied this nomenclature 
to screening participation data over the 2 rounds of the 
NBCSP.
Eligibility for screening invitations
 Round 1 invitations were issued to all South 
Australians who were recorded by Australia’s Health 
Insurance Commission or the Australian government 
Department	of	Veterans	Affairs	as	being	aged	55-74	on	
1 January 2003 and residing in any one of 9 postcode 
specific	 areas	 in	 urban	Adelaide.	The	 same	population	
was invited again in Round 2 with the exception of those 
who had opted to be removed from the NBCSP register 
or were recorded as deceased (Young, 2009).
Study population
 Round 1 (Pilot) invitations were issued to 18,431 South 
Australians. Of this population, 1279 people opted out 
and 574 people were recorded as deceased before round 
2	invitations	(NBCSP	Phase	1)	were	issued.	The	final	data	
set comprised information from 16,578 invitees. This was 
reduced to 16,433 after exclusion of people whose age or 
postcode was subsequently found not to match round 1 
eligibility criteria.
The NBCSP process
 Invitations to screen were posted to all eligible 
people and included a faecal immunochemical test (FIT). 
Two different FITs (InFormTM, Enterix Australia or 
DetectTM, Bayer Health Care) with similar performance 
characteristics but different procedures for use were 
distributed in round 1. The invitation process for the 
second	round	was	identical	although	only	DetectTM	was	
distributed. Participants returned specimens to a central 
laboratory	and	received	written	notification	of	the	result.	
Test positive participants were encouraged to consult their 
GP for referral for colonoscopy.
Data acquisition
 Ethical approval for the project was obtained from 
the Research and Ethics Committee of the Repatriation 
General	Hospital	Daw	Park	and	from	the	Departmental	
Ethics Committee of the Australian Government 
Department	 of	Health	 and	Ageing.	 Final	 approval	 for	
data release was granted by the NBCSP data custodian 
Medicare Australia. 
Data fields
	 Available	data	fields	relevant	to	the	study	aims	were:	
date	of	birth,	sex,	first	and	second	round	address	postcodes,	
first	round	FOBT	type	offered	(Detect	was	offered	to	all	
invitees in round 2), participation status for rounds 1 and 
2, and round 1 FOBT result. 
	 Date	 of	 birth	was	 converted	 to	 age	 on	 1	 January	
2003 and grouped into 5 year age bands. Postcode 
was converted to the equivalent Index of Relative 
Socioeconomic	Advantage	 and	Disadvantage	 (!RSAD)	
value (AIHW, 2006), and grouped by quintiles. 
Factors associated with participatory behaviours
	 We	undertook	a	stepwise	analysis	of	the	data	firstly	
using univariate Chi2 analyses, followed by multivariate 
analyses by generalised estimating equations (GEE, SPSS 
Version	17).	
 In our multivariate analyses we compared the 
characteristics	 of	Dropouts	 relative	 to	Re-Participants,	
Never Participants to Late Entrants and Re-Participants 
with Never Participants.
Results 
Re-screening rates
 Patterns of participatory behaviour after 2 rounds of 
invitations from the NBCSP are shown in Table 1. Of 
the 16,433 people who were offered screening in both 
rounds and who satisfied the data inclusion criteria, 
40.5% completed both offers and were categorised as 
Re-Participants. Never Participants comprised 38.7% and 
61.3% participated at least once over the two rounds of 
Table 1. Screening Participation Rates for Round 1 and 
Round 2 of NBCSP Pilot Invitees in South Australia
Participation n %
Round	1:		 Participants	 8345	 50.8
 Non-Participants 8088 49.2
 Total 16433
Round	2:	 Re-participants	 6656	 40.5
	 Dropouts	 1689	 10.3
 Late Entrants 1726 10.5
 Never Participants 6362 38.7
 Total 16433
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Table 2. Number and Proportion of Round 2 Invitees in Each Participation Category by Invitee Characteristic, 
and Significant Univariate Associations
Invitee	characteristic	 Behaviour	category	 Comparison	between	behavioural	categories	(Χ2)
	 RP	 NP	 DP	 LE	 All	 RP	vs	DP	 NP	vs	LE	 RP	vs	NV
 n % n % n % n %
Age (years)
 55-59 1957 29.4 2059 32.0 459 27.2 656 38.0
 60-64 1594 23.9 1347 21.3 328 19.4 394 22.8 121.1** 43.7** 35.2** 23.5**
 65-69 1614 24.2 1487 23.5 402 23.8 368 21.3
 70-74 1491 22.4 1487 23.5 500 29.6 308 17.8
Gender            
 Female 3687 55.4 3360 52.8 981 58.1 868 50.3 29.6** 3.9* 3.4 8.7*
 Male 2969 44.6 3002 47.2 708 41.9 858 49.7
SES	(IRSAD	quintile)
 1 (lowest SES) 310 4.7 597 9.6 114 6.7 110 1.4
 2 963 14.5 1183 18.6 288 17.1 293 3.6
 3 351 5.3 552 8.7 100 5.9 98 5.7 292.8** 25.7** 43.7** 275.2**
 4 1272 19.1 888 14.0 324 19.2 279 16.2
 5 (highest SES) 3760 56.5 3142 49.4 863 51.1 946 54.8
Postcode change
 No Change 6027 90.5 3110 48.9 842 49.9 808 46.8 10.0* 9.0** 0.2 3.9*
 Change 629 9.5 667 10.5 201 11.9 174 10.1
FOBT Type at Pilot 
	 DetectTM 3513 52.8 3110 48.9 842 49.9 808 46.8 30.0** 4.6* 2.3 19.8**
 InFormTM 3143 47.2 3252 51.1 846 50.1 918 53.2
Pilot Test Result
 Negative FOBT 6129 92.1   1313 77.7
 Positive FOBT 499 7.5   310 18.4    340.3**
 Inconclusive FOBT 28 0.4   66 0.8
*	p<0.05,	**p<0.01,	SES	was	classified	using	postcode	(at	round	1)	and	the	ABS	Index	of	Relative	Socioeconomic	Advantage	and	Disadvantage	
(IRSAD)	for	2006,	Two	people	had	postcodes	that	did	not	correspond	to	the	SEIFA	codes	and	could	not	be	classified.	Their	data	are	excluded	from	
this	table,	RP:	Re-participation,	NP:	Never	Participation,	DP:	Dropout,	LE:	Late	Entry
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Table 3. Joint Predictors of Screening Behaviour
 Dropouts	vs	Re-Participants	 Late	Entrants	vs	Never	Participants	 Re-Participants	vs	Never	Participants
 Risk Ratio p-value 95% CI Risk Ratio p-value 95% CI Risk Ratio p-value 95% CI
Age band (years) 55-59a 1.00 1.00 1.00 1.00   1.00
 60-64 0.88 0.05 0.78, 1.00 0.95 0.34 0.85, 1.06 1.12 0.01 1.07, 1.17
 65-69 1.00 0.96 0.89, 1.13 0.85 0.01 0.76, 0.95 1.08 0.01 1.03, 1.13
 70-74 1.22 0.01 1.09, 1.37 0.72 0.00 0.64, 0.82 1.04 0.13 0.99, 1.09
Gender Femalea 1.00   1.00   1.00
 Male 0.92 0.04 0.84, 0.99 1.06 0.19 0.97, 1.15 0.95 0.01 0.92, 0.98
SES quintile 1 (lowest SES)a 1.00   1.00   1.00
 2 0.88 0.17 0.73, 1.06 1.29 0.01 1.05, 1.57 1.31 0.01 1.18, 1.45
 3 0.88 0.25 0.70, 1.10 0.98 0.86 0.76, 1.26 1.14 0.04 1.00, 1.2
 4 0.83 0.05 0.69, 1.00 1.52 0.01 1.25, 1.86 1.73 0.01 1.57, 1.90
 5 0.76 0.01 0.65, 0.90 1.47 0.01 1.23, 1.76 1.6 0.01 1.45, 1.75
Postcode change No changea 1.00 1.00 1.00 1.00   1.00
 Change 1.22 0.01 1.07, 1.38 0.94 0.38 0.82, 1.08 0.95 0.07 0.90, 1.01
FOBT	type	at	Pilot	 DetectTMa 1.00 1.00 1.00 1.00   1.00
 InformTM 1.09 0.05 1.00, 1.18 1.06 0.16 0.98, 1.16 0.93 0.01 0.90, 0.96
Pilot test result Negativea 1.00 1.00 1.00
 Positive 2.10 0.01 1.90, 2.33
 Inconclusive 3.81 0.01 3.29, 4.40
aReference group for categorical predictors
invitations.	In	the	second	round	Dropouts	comprised10.3%	
which was balanced by 10.5%of the invited population 
who were Late Entrants.
Associations with participatory behaviours
 Results of univariate analyses are shown in Table 2. 
Comparisons included between all groups, Re-Participants 
versus	Dropouts,	Never	Participants	versus	Late	Entrants	
and Re-Participants versus Never Participants. 
 When all participatory groups were compared together, 
significant	heterogeneity	between	groups	was	observed	
for all variables (excluding FOBT test result as this 
was not available for non-participants). In two-group 
comparisons,	Re-Participants	differed	significantly	from	
Dropouts	 for	 all	 available	demographic	 characteristics,	
as did Re-Participants from Never Participants. All 
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variables	significant	at	the	univariate	level	were	included	
in multivariate GEE models to identify joint predictors of 
rescreening behaviours.
Dropouts compared to Re-participants
	 Table	3	shows	that	Dropouts	were	more	likely	to	be	
aged 70-74, and less likely to be aged 60-64. Men were 
significantly	less	likely	to	dropout	than	women.	People	in	
the	highest	two	SES	groups	were	significantly	less	likely	
to dropout than people in the lowest SES group. Those 
who	had	a	different	postcode	between	the	first	and	second	
round screening offers were also more likely to dropout. 
 Invitees who had been offered InFormTM in round 1 
were	more	likely	to	be	Dropouts	in	round	2.	The	result	of	
the	first	round	FOBT	result	also	influenced	second	round	
uptake	as	people	who	 tested	positive	 in	 the	first	 round	
were less likely to participate in the second round. Those 
who	received	an	inconclusive	result	in	the	first	round	were	
also more likely to reject a second offer of screening than 
people with a negative test.
Late entrants compared to never participants
 People aged 65-69 years and 70-74 years were 
significantly	less	likely	to	become	Late	Entrants	(Table	
3) and those in the highest two SES groups were more 
likely to become Late Entrants.
Re-participants compared to never participants
 Re-participants differed from Never Participants in 
all characteristics, except postcode change. Women and 
people aged 60-69 years, those from higher SES and those 
who received InFormTM in round 1 were more likely to be 
Re-Participants in the second round.
 
Discussion
In	 this	 study	we	 identified	 socio-demographic	 and	
screening program variables associated with different 
patterns of participatory behaviour following two rounds 
of an organised, population-based screening program for 
CRC. 
We	propose	a	nomenclature	that	allows	the	identification	
after two rounds of invitations of population sub-groups 
with stable screening behaviour (Re-Participants and 
Never	Participants),	and	changeable	behaviour	(Dropouts	
and	Late	Entrants)	 relative	 to	first	 round	participation	
status. We did not use the term ‘relapse’ to describe 
behaviour of second round non-participation following 
first round participation as this already has distinct 
meaning in the medical literature. In programs of more 
than two rounds the changeable category could be further 
sub-divided into groups where the change is sustained or 
unsustained.
It is important to examine participation patterns round 
by round to identify predictors of different behaviour 
patterns and to determine if particular sub-populations 
are	more	or	less	likely	to	demonstrate	specific	screening	
behaviours. Understanding the behaviour of people in 
screening programs, especially why they fail to participate 
or	decline	further	screening	after	first	participating	(hence	
‘Dropout’),	should	allow	the	development	of	strategies	
that target these behaviours and thus improve re-screening 
rates. 
As one goal was to identify characteristics of those 
who declined to participate, it was important to identify 
characteristics associated with Never-Participants and 
Dropouts.	Conversely,	characteristics	associated	with	late	
entry to a screening program could suggest strategies to 
apply	to	first	round	non-participants	to	improve	second	
round participation. 
Our analysis has shown that in the South Australian 
cohort offered 2 rounds of screening, participation was 
51%	in	the	first	round	and	this	rate	was	maintained	in	the	
second round. A program participation rate target of 70% 
was proposed for the NBCSP (AIHW, 2007) based on the 
assumption that at least 20-25% of the target population 
is unsuitable for FOBT-based screening alone because 
of their previous diagnostic history, recent testing or 
higher level of risk (BCSPMESC, 2005). Thus there is 
a considerable gap between actual participation rate and 
the target rate, indicating the need to identify strategies 
to improve participation in re-screening. 
The re-screening rate in the NBCSP differs from 
the English Bowel Cancer Screening Program Pilot 
where	second	round	participation	fell	significantly	from	
58.5% in the initial round to 51.9% in the second round. 
The difference may be partly due to the higher initial 
participation rate in the English Pilot (UKCCSPG, 2004) 
combined with the use across the UK programs of the less 
preferred guaiac FOBT (Cole et al., 2003).
The	first	 and	 second	 round	participant	 populations	
comprised of slightly different but overlapping populations 
because people who declined screening in round 2 but 
had	previously	participated	in	the	Pilot	(Dropouts)	were	
replaced by an equivalent number of new participants 
from the group who had earlier declined screening 
(Late	Entrants).	This	mirrors	findings	from	the	Scottish	
feasibility	trials	where	Dropouts	were	also	balanced	by	
Late Entrants (Steele et al., 2009).
Reports on rates of re-participation in the literature are 
scarce and inconsistent, and vary depending on country 
and whether the data comes from randomised controlled 
trials, feasibility studies or full programs (Jansen, 1984; 
Kewenter et al., 1988; Hardcastle et al., 1996; Hart et al., 
1997; Faivre et al., 1999; Mandel et al., 1999; Jorgenson 
et al., 2002; Weller et al., 2007; Lindholm et al., 2008; 
Steele	et	 al.,	 2009).	Some	studies	 failed	 to	 invite	first-
round non-participants in subsequent rounds (Kronborg 
et al., 1989) although our results show that this would be 
unwise in organised programs because such people may 
become Late Entrants. The NBCSP data presented here 
are consistent with second round participation rates seen in 
feasibility trials of occult blood-based screening delivered 
by mail (von Euler-Chelpin et al., 2010).
Over time and increasing numbers of rounds of 
screening offers, individuals may move from one 
behavioural group to another as a result of a complex 
interaction of psychosocial factors or a consequence 
of diagnostic procedures and change in medical status. 
Understanding why people change behaviour, especially 
why they decline after first participating should aid 
development of strategies to keep people engaged in 
Archived at Flinders University: dspace.flinders.edu.au
Asian Pacific Journal of Cancer Prevention, Vol 13, 2012 5993
DOI:http://dx.doi.org/10.7314/APJCP.2012.13.12.5989
Re-participation in Screening for Colorectal Cancer in Australia
screening.
Although data were available for only a modest set 
of	variables,	we	identified	particular	characteristics	that	
were associated with behaviours of interest. Our primary 
goal was to identify factors associated with dropping 
out. Multivariate analyses indicated that, relative to re-
participation, dropping out was jointly associated with 
being female, being in the oldest age group, (70-74 years 
at	first	invitation),	being	from	lower	SES	and	having	had	
a	positive	or	inconclusive	test	result	in	the	first	round.	
The relationship of age with FOBT-based CRC 
screening behaviour is complex and non-linear. Many 
groups, including our own (Cole et al., 2003; von Euler-
Chelpin et al., 2010), have already reported that after a 
first	screening	offer	targeted	at	a	population	aged	50-74,	
invitees aged 60-69 are most likely to participate, while 
those aged 50-59 and 70-74 are less likely to participate. 
Results from this study show that, relative to Re-
Participants,	Dropouts	were	more	likely	to	be	70-74	years	
of age, the oldest age band offered screening, consistent 
with	previous	findings	(Thomas	et	al.,	1995).	Examination	
of Late Entrants revealed that invitees in the oldest age 
band are least likely to take up a second round invitation 
if they did not previously participate. These observations 
might be explained by the fact that the second offer in 
the NBCSP was made approximately 3 years after the 
first,	and	many	who	were	in	this	age	band	at	first	offer	
would be approaching 80 years of age and may now 
have other health priorities. However, the association is 
consistent with literature that suggests that older people 
may	experience	difficulty	adhering	to	health	practices	like	
medication	compliance	 (Doggrell,	2010).	These	 results	
highlight the fact that special efforts, perhaps through 
targeted invitations or reminders, should be used to 
encourage the older age group who have the highest risk 
for developing CRC to maintain participation in CRC 
screening. 
The effect of gender on participation across the two 
rounds of screening was also complex. Although women 
are	more	likely	to	participate	at	an	initial	offer	(Vernon,	
1997; Cole et al., 2003; von-Euler-Chelpin et al., 2010) 
and comprised the majority of the Re-Participant group, 
men were more likely than women to re-participate if 
they had participated at the initial offer of screening. This 
finding	confirms	other	research	showing	that	men	are	more	
adherent than women in ongoing CRC screening (Gili et 
al., 2006; Sewetch et al., 2007; Fenton et al., 2010; Janda 
et al., 2010).
The association of re-participation with socioeconomic 
status was similar to that found after an initial offer 
(Farrands et al., 1984) and followed a linear trend, with 
people in the lower SES groups most likely to dropout in 
the second round of a screening program while those of 
higher SES were most likely to re-participate, consistent 
with previous reports (Neilson and Whynes, 1995; Weller 
et al., 2007; Ward et al., 2011) Also, people in the highest 
two SES groups were more likely to enter into the program 
at the second round if they had not participated previously. 
Higher SES invitees were more likely to have screened 
at least once in the program compared to those of lower 
SES. These observations together highlight the role of 
socioeconomic status and inequality in CRC screening 
participation and re-participation. 
Dropping	out	was	also	associated	with	being	offered	a	
different FOBT test type in the second round compared to 
the	first,	as	well	as	with	receiving	an	inconclusive	result	
in	the	first	round.	This	implies	that	participants	wish	for	
a stable and consistent program, and are discouraged by 
returning an inconclusive result, which could be seen by 
the participant as a consequence of an inferior screening 
program. A lower re-participation rate for people returning 
a positive test result was possibly due to having undergone 
follow-up colonoscopy and change in actual or perceived 
risk level. We analysed the results on a program basis 
rather than a health status basis as we were not able 
to ascertain who did proceed to colonoscopy; future 
studies	need	to	define	how	much	this	contributes	to	non-
participation in a program. 
The strength of the research is that the population 
sample comprised all people in the target age range living 
within	defined	areas,	identified	from	federal	government	
health insurance enrolment record data (AIHW, 2007) so 
that there are unlikely to be sampling biases. Similarly, 
the NBCSP is organised by federal government which 
is likely to provide some reassurance as to the value of 
screening and the credibility of the screening program, 
potentially removing some variables that might impact 
on participation rates. 
The inability to examine additional potential predictors 
of	 participation	 limits	 the	 findings	 of	 the	 study.	 It	 is	
possible that variables including language spoken at home, 
education, chronic ill health, marital status and mobility 
may all impact on ongoing participation in screening and 
future	 research	 should	 examine	 the	 influence	 of	 these	
variables. 
Nonetheless,	 the	 identification	 of	 population	 sub-
groups with different participatory behaviours allows 
targeted interventions aimed at improving re-participation 
in those sub-populations. It would be feasible to develop 
re-invitation	letter	formats	that	appeal	specifically	to	those	
sub-groups that are more likely dropout, or to encourage 
those	that	did	not	participate	in	a	first	offer	to	enter	the	
program later on. Research is needed to trial different letter 
formats to determine if targeted approaches are successful.
The descriptive framework is potentially applicable to 
any number of screening rounds, and was developed to 
identify sub-populations in ongoing screening programs 
that potentially could be offered targeted invitations 
to improve re-participation rates. It addresses change 
in behaviour as we consider that various factors such 
as	 personal	 circumstances	 and	 conflicting	 guidelines	
around the frequency of FOBT screening for faecal blood 
contribute to whether a person participates in consecutive 
offers. Categorising invitees according to sustained 
behaviour over multiple rounds of offers should minimise 
the	influence	of	more	temporary	factors	on	participation	
and sub-group allocation. 
In conclusion, we propose a simple descriptive 
framework CRC screening over multiple rounds based on 
stable or changing behaviour, and the concept of sustained 
change. We documented participation over 2 rounds of 
screening offers from Australia’s NBCSP, applied the 
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descriptive	framework	to	test	its	practicality	and	identified	
invitee characteristics that predict participatory behaviours 
of particular interest, especially the characteristics of 
those who failed to re-participate. Our research has 
demonstrated	that	age,	gender	and	SES	were	all	significant	
demographic correlates of participation in second round 
CRC screening in the NBCSP. To improve re-participation 
rates, re-invitation formats could incorporate different 
specific	messages	 for	 particular	 sub-populations.	This	
approach needs to be tested, either within the NBCSP or 
in smaller trials.
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